Fractyl company profile: Investors, funding, valuation and more
November 25, 2015
All information for Fractyl Laboratories' profile has been sourced from the PitchBook Platform. You can request a free trial here to get full access to all the information below, including valuations, funding history, investor profiles and more.
Fractyl Company Description
Developer of medical devices for treatment of chronic diseases. The company offers medical devices for developing therapies used in the treatment of large, complex, and costly chronic diseases. It is particularly focused on improving the health of people with Type 2 diabetes.
Fractyl Laboratories currently has five active investors, including early stage investors General Catalyst, Bessemer Venture Partners and Domain Associates. Most recently, Deerfield Management made an investment in November 2015. See the list of investors below and get full access to their profiles by requesting a trial or logging into your PitchBook account.